Biostax Corp (BTAX)

[noreen]

No. So far, it has only passed Phase 2 trials for Crohn's. Still needs to pass Phase 2b and Phase 3, and get marketing approval, etc etc etc. Still probably at least 2 years away.

www.cytocom.com/investors/

Go to page 8 of the powerpoint presentation. IMUN owns 13.3% of Cytocom, but Cytocom is a private company. So they actually could be further along than Phase 2, and just not updated outsiders yet. That powerpoint has not been updated for over a year. It says Phase 2b for Crohn's was supposed to be in 2015. We have no idea we're that at with that, because they don't update the public (they don't have to with a private company).